CGF – UBS rates the stock as Neutral
The broker retains a Neutral rating and raises the target to $6.25 from $6.10.
Read MoreThe broker retains a Neutral rating and raises the target to $6.25 from $6.10.
Read MoreThe broker maintains its Speculative Buy rating and $1.42 target price.
Read MoreOutperform rating and $30 target retained.
Read MoreBuy rating and $5.93 target price are unchanged.
Read MoreThe broker retains an Outperform rating with a $13.91 target.
Read MoreThe broker retains an Outperform rating with a $13.91 target.
Read MoreThe Buy rating and $30 target price are unchanged.
Read MoreTarget is reduced to $0.50 from $0.60.
Read MoreThe broker maintains its Add rating and $0.33 target price.
Read MoreUBS resumed coverage of Domino’s Pizza with a Neutral rating and $150 target.
Read MoreMacquarie downgrades to Underperform from Neutral. Target is lowered to $32.00 from $39.00.
Read MoreBuy rating and $34.50 target maintained.
Read MoreThe Add rating and $10.80 target are unchanged.
Read MoreThe Add rating and $0.90 target are retained.
Read MoreAfter a recent share price fall, and with the current share price -20% adrift of Credit Suisse’s $5.92 target price, the broker upgrades its rating to Add from Hold.
Read MoreCredit Suisse to lower its target price to $3.20 from $3.30 and retains its Underperform rating.
Read MoreUBS raises its target price for Fletcher Building to NZ$8 from NZ$7.85 and increases its rating to Buy from Neutral.
Read MoreThe Speculative Buy rating is retained and the target price increases to $0.32 from $0.24.
Read MoreThe Neutral rating and target price of $78.00 are retained.
Read MoreThe broker makes minor changes to estimates and reduces the target to $6.11 from $6.15. Outperform maintained.
Read MoreThe Buy rating and $5.15 target are maintained.
Read MoreOutperform rating and target lifted to $0.40 from $0.35.
Read MoreUBS lifts its target price to $13.50 from $13.20.
Read MoreOutperform rating and $4.15 target are unchanged.
Read MoreWoodside Petroleum’s estimates are raised by 8%. Target is raised to $27.25 from $27.10. Outperform retained.
Read MoreEstimates are upgraded and a Buy rating is reiterated. Target rises to $4.10 from $3.40.
Read MoreUBS retains a Buy rating and raises the target to $3.85 from $3.10.
Read MoreCiti reduces the target to $0.60 from $0.65 and maintains a Buy/High Risk rating.
Read MoreMorgans lifts its FY22 estimates and increases its target price to $0.58 from $0.56. The Add rating is unchanged.
Read MoreThe broker lifts estimates for earnings per share in 2021 by 10% but makes no changes to the $1.20 target. Outperform rating maintained.
Read MoreThe broker retains its Outperform rating and lifts its target price to $16.11 from $15.66.
Read MoreOutperform rating and $1.70 target unchanged.
Read MoreOutperform retained. Target rises to $3.98 from $3.30.
Read MoreMorgans moves to a Hold rating from Add after indicative offer for $10.35 in cash. The target price rises to the $10.35 bid price from $8.35.
Read MoreThe stock is still considered expensive and a Neutral rating is maintained. Target is raised to NZ$32.30 from NZ$31.84.
Read MoreThe Outperform rating and $40 price target are unchanged.
Read MoreThe broker retains its Add rating and reduces its target price to $6.85 from $7.61.
Read MoreUnderperform maintained. Target is reduced to $0.19 from $0.22.
Read MoreBuy retained. Target is unchanged at NZ$5.35.
Read MoreThe $315 target and Neutral rating are unchanged.
Read More